Salarius Pharmaceuticals(SLRX) - 2020 Q4 - Earnings Call Transcript

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) Q4 2020 Earnings Conference Call March 18, 2021 4:30 AM ET Company Participants Jason Rando - EVP & COO, Tiberend Strategic Advisors David Arthur - CEO, President & Director Mark Rosenblum - EVP, Finance & CFO Nadeem Mirza - SVP, Clinical Development Daniela Santiesteban - Director, Research and Business Development Conference Call Participants Wangzhi Li - Ladenburg Thalmann & Co. Aydin Huseynov - The Benchmark Company Hunter Diamond - Diamond Equity Research Op ...